Healthcare >> CEO Interviews >> October 12, 2001
JAY M. SHORT, PhD, a founding member of Diversa Corporation, has served
as Chief Technology Officer and Director of the company since its
inception in 1994. He assumed the additional roles of President in 1998
and Chief Executive Officer in 1999. Prior to joining Diversa
Corporation, Dr. Short served as President of Stratacyte, Inc. and Vice
President of Research & Development and Operations for Stratagene
Cloning Systems, both molecular biology companies based in La Jolla,
California. Dr. Short serves as a Director for Invitrogen, a leading
biotechnology company in the area of gene expression, based in Carlsbad,
California, and StressGen, focusing on the medical application of stress
proteins. Dr. Short was the recipient of two first-place awards granted
by the University of California, San Diego, Innovations in Biotechnology
Connect Program. And Dr. Short's grant program was selected in the top
1% of research programs in the United States for commercializing new
products funded by the SBIR program. He has authored more than 80
publications, is named inventor for over 50 patents, and currently
serves on the US National Research Council Panel for Chemical Science
and Technology. Profile
Dr. Short: Diversa Corporation was founded in 1994 as a sister company
to Human Genome Sciences. It was originally known as
